TMCnet News

Uptrend Call Working As Alnylam Pharmaceuticals Stock Rises 20.1% (ALNY)
[April 04, 2013]

Uptrend Call Working As Alnylam Pharmaceuticals Stock Rises 20.1% (ALNY)


Apr 04, 2013 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Alnylam Pharmaceuticals (NASDAQ:ALNY) on December 12th, 2012 at $18.85. In approximately 4 months, Alnylam Pharmaceuticals has returned 20.08% as of today's recent price of $22.63.



In the past 52 weeks, shares of Alnylam Pharmaceuticals have traded between a low of $9.51 and a high of $25.80 and are now at $22.63, which is 138% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.2% while the 200-day MA has risen 0.9%.

Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.


SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Alnylam Pharmaceuticals shares.Log in and add Alnylam Pharmaceuticals (ALNY) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

[ Back To TMCnet.com's Homepage ]